This webinar introduces key updates in acute ischemic stroke management, focusing on how modern decision‑making integrates time‑sensitive evaluation, advanced imaging, and AI‑supported tools. It also reviews the expanded…
Daniel R. Schimmel, MD, explains how balloon pulmonary angioplasty (BPA) uses balloons and specialized catheters to open narrowed vessels in the lungs to improve circulation and reduce symptoms…
NEW YORK (Reuters Health) – In a study of nearly 7000 men, large body size at age 20 years and subsequent weight gain were both identified as independent…
NEW YORK (Reuters Health) – From 1985 to 2007, the initial CD4+ cell counts seen at diagnosis in HIV-infected patients in the US have fallen, suggesting that the…
NEW YORK (Reuters Health) – In patients with newly diagnosed type 1 diabetes, high-dose immune ablation followed by autologous nonmyeloablative hematopoietic stem cell transplantation (HSCT) induces significant and…
NEW YORK (Reuters Health) – In children exposed in utero to methamphetamine, MRI findings suggest alterations in white matter maturation, according to a report in the April 15th…
NEW YORK (Reuters Health) – New research suggests that marijuana use may increase the risk of testicular germ cell tumors (TGCTs), primarily nonseminoma types. According to the report…
NEW YORK (Reuters Health) – After the development of coronary artery disease (CAD), a subsequent diagnosis of depression is associated with an increased incidence of heart failure, even…
NEW YORK (Reuters Health) – Despite the fact that up to one third of patients with severe dementia receive enteral tube feeding, evidence is lacking that this practice…
NEW YORK (Reuters Health) – Assessing kidney function with both the estimated glomerular filtration rate (eGFR) and with urinary albumin levels can help predict whether chronic kidney disease…
NEW YORK (Reuters Health) – Desvenlafaxine, a serotonin-norepinephrine reuptake inhibitor, is a safe and effective treatment for hot flushes in postmenopausal women, according to a report in the…
NEW YORK (Reuters Health) – Bezafibrate, a pan-PPAR agonist used widely for treating dyslipidemia in the UK, appears to prevent or delay the development of type 2 diabetes,…
